ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,424Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 2056

$525K Total Retail Price of All Prescriptions

Rank: 59 out of 2056

481 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,619 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
PRAVASTATIN SODIUM 399 368 1 20
LISINOPRIL 339 287 2 1
OMEPRAZOLE 278 207 3 4
GABAPENTIN 254 182 4 14
TRAMADOL HCL 244 175 5 27
HYDROCODONE-ACETAMINOPHEN 236 179 S3 6 5
WARFARIN SODIUM 234 218 7 12
LEVOTHYROXINE SODIUM 234 195 7 3
HYDROCHLOROTHIAZIDE 230 204 9 7
AMLODIPINE BESYLATE 203 190 10 6
LOSARTAN POTASSIUM 173 130 11 13
FUROSEMIDE 149 138 12 9
METOPROLOL SUCCINATE 130 98 13 19
TAMSULOSIN HCL 126 126 14 28
CITALOPRAM HBR 125 114 15 15
SPIRIVA 120 104 16 42
POTASSIUM CHLORIDE 120 99 16 18
METOPROLOL TARTRATE 114 89 18 11
ATENOLOL 108 85 19 10
CARVEDILOL 108 96 19 35
PROAIR HFA 107 76 21 29
DONEPEZIL HCL 107 107 21 37
METFORMIN HCL 103 94 23 8
MELOXICAM 101 59 24 47
SIMVASTATIN 101 68 24 2
DIGOXIN 100 81 26 53
ATORVASTATIN CALCIUM 95 81 27 17
NAMENDA 82 82 28 62
GLIPIZIDE 79 73 29 39
BUSPIRONE HCL 79 33 29 102
ISOSORBIDE MONONITRATE ER 77 63 31 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 64 31 34
POLYETHYLENE GLYCOL 3350 76 56 33 50
FENTANYL 72 68 S2 34 56
ZOLPIDEM TARTRATE 72 54 34 23
NORTRIPTYLINE HCL 69 63 36 100
RANITIDINE HCL 66 42 37 22
PAROXETINE HCL 66 32 37 58
PANTOPRAZOLE SODIUM 65 47 39 55
DILTIAZEM 24HR CD 65 52 39 120
BUPROPION HCL SR 63 43 41 104
TRAZODONE HCL 60 38 42 21
CYMBALTA 60 0 42 59
LOSARTAN-HYDROCHLOROTHIAZIDE 59 51 44 78
ADVAIR DISKUS 57 51 45 51
ALLOPURINOL 56 56 46 32
DOXAZOSIN MESYLATE 55 55 47 76
PREDNISONE 53 40 48 38
VENLAFAXINE HCL ER 52 29 49 82
FLUOXETINE HCL 52 24 49 33
CRESTOR 51 50 51 30
OXYBUTYNIN CHLORIDE ER 50 45 52 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.